Related Experiment Videos
Irradiation therapy for gallbladder carcinoma: recent advances
S Houry1, A Barrier, M Huguier
1Department of Digestive Surgery, Tenon Hospital, University Paris VI, 4 rue de la Chine 75020 Paris, France.
Journal of Hepato-Biliary-Pancreatic Surgery
|April 17, 2002
Summary
Radiotherapy offers a slight survival benefit for gallbladder carcinoma patients. Adjuvant or palliative radiation therapy, particularly intraoperative boosts and postoperative external beams, improves local control, especially after tumor resection.
Area of Science:
- Oncology
- Radiation Oncology
Background:
- Gallbladder carcinoma is often considered radioresistant.
- The efficacy of radiotherapy in gallbladder cancer remains under-evaluated.
Purpose of the Study:
- To assess the value and impact of radiation therapy in gallbladder carcinoma.
- Evaluate radiotherapy's role in both resected and palliative settings.
Main Methods:
- Systematic review of publications on gallbladder carcinoma radiotherapy (1974-2000).
- Evaluation of external beam radiation therapy, intraoperative radiation therapy, and brachytherapy.
- Analysis of outcomes in surgically resected and palliative treatment groups.
Main Results:
- Radiotherapy demonstrated local tumor control and size reduction.
- Adjuvant or palliative radiotherapy showed a modest survival improvement.
- Optimal benefit observed in tumors with microscopic residual disease post-resection.
Conclusions:
- Radiotherapy is a safe modality that offers a slight survival advantage in gallbladder carcinoma.
- Further research is required to explore combined radiotherapy and chemotherapy regimens.